Dietary Folate Intake May Decrease Risk Of Bladder Cancer
Tuesday, 09 May 2006
BERKELEY, CA (UroToday.com) - Genetic alterations, epigenetic events and environmental exposures all contribute to the development of bladder cancer. It is suggested that some factors, such as vitamins can decrease the risk of bladder cancer. Dr. Schabath and colleagues hypothesized that dietary folate, which is involved in DNA methylation may have a chemopreventive effect in the bladder. Their study results appeared in Nutrition and Cancer.
read more
|
Apoptosis Receptor Holds Potential As Urinary Marker For Bladder Cancer
Friday, 05 May 2006
BERKELEY, CA (UroToday.com) - Cystoscopy remains the gold standard for detection of recurrent transitional cell carcinoma (TCC) of the bladder. Cytology and other markers are used to improve sensitivity and potentially decrease the frequency of cystoscopies.
read more
|
NMP22® BladderChek® Test to be Introduced to U.S. Gynecologists at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting
Thursday, 04 May 2006
Women Have a Disproportionately Higher Death Rate from Bladder Cancer than Men
The Company is Introducing the Only FDA Approved Point-of-care Test for Both the Detection and Monitoring of Bladder Cancer to Women’s Healthcare Specialists
Recent Clinical Data Showed the Test Detected 100% of Dangerous Tumors in Women at Risk for Bladder Cancer
read more
|
Wisconsin Urologist Reports Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
Thursday, 04 May 2006
A larger percentage of women than men have life-threatening (or advanced) bladder cancer at diagnosis. The incidence rate is going down in men but up in women. Therefore, in women, symptoms of common urinary infection like urgency and blood, need to be investigated thoroughly so not to miss bladder cancer.
read more
|
European Urology - Management of BCG ?Failures?
Monday, 01 May 2006
Bacillus Calmette-Guérin (BCG) into the bladder has been demonstrated as an efficacious adjuvant treatment for superficial bladder cancer.
read more
|
Single-Dose Carboplatin Comparable To Prophylactic Radiotherapy For Stage I Seminoma: Results Of A Randomized Trial
Thursday, 13 April 2006
BERKELEY, CA (UroToday.com) - The risk of relapse for patients with stage I seminoma has traditionally ranged between 10 and 15%, depending on the local pathological characteristics of the tumor.
read more
|
Prolonged Survival Linked To Intravenous Vitamin C Seen In Three Cancer Patients
Tuesday, 11 April 2006
NEW YORK (Reuters Health) - Researchers at the National Institutes of Health and colleagues in Canada report three cases in which high-dose intravenously administered vitamin C apparently led to longer-than-expected survival in patients with advanced cancer. Two of them show long-term survival without evidence of disease.
read more
|
Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
Thursday, 06 April 2006
BERKELEY, CA (UroToday.com) - EAU 2006 - XXI Annual Congress
INTRODUCTION AND OBJECTIVE: Both cystoscopy and a urine test are frequently used for the initial diagnosis of bladder cancer.
read more
|
Immediate Intravesical Mitomycin C After Bladder Tumor Resection Safe
Tuesday, 04 April 2006
NEW YORK (Reuters Health) - Intravesical instillation of mitomycin C is feasible and safe to perform in the operating room immediately after transurethral resection of superficial bladder cancers, UK-based clinicians report.
read more
|
Tissue-Engineered Bladders Successfully Used To Augment Cystoplasty
Tuesday, 04 April 2006
NEW YORK (Reuters Health) - For the first time, researchers have bioengineered a bladder using cultured autologous cells to reconstruct human bladders damaged by congenital abnormalities, investigators report in The Lancet, published online on April 4.
read more
|
Prothymosin-Alpha May Help Spot Bladder Cancer
Monday, 03 April 2006
NEW YORK (Reuters Health) - Urinary levels of nuclear protein prothymosin-alpha may be of use in finding and monitoring bladder cancer, according to Taiwanese researchers.
read more
|
Serum Tumor Markers Predict Extravesical Disease In Clinical Stage T2 Bladder Cancer
Thursday, 30 March 2006
BERKELEY, CA (UroToday.com) - Bladder cancer clinical staging is notoriously poor in patients with muscle invasive disease.
read more
|
Virtual Cystoscopy Produces Real Results
Thursday, 30 March 2006
NEW YORK (Reuters Health) - Virtual cystoscopy with CT imaging using a dilute contrast medium and computer rendering is effective in detecting certain bladder tumors, researchers report in the March issue of the Journal of Urology.
read more
|
Women Have a Disproportionately Higher Death Rate from Bladder Cancer than Men
Thursday, 23 March 2006
BERKELEY, CA (UroToday.com) - CLINICAL BRIEF: (Toronto, March 23, 2006, 6:30 PM EST) Society for Gynecologic Investigation (SGI), Scientific Poster 332, "Detection of Bladder Cancer in Women Using a Point-of-Care Assay."
read more
|
Post-Operative Instillation Of Intravesical Mitomycin C Is Safe
Friday, 10 March 2006
BERKELEY, CA (UroToday.com) - Recurrence rates following transurethral resection of bladder tumors (TURBT) are significant.
read more
|
Study Assesses NMP22 in Combination With Cystoscopy To Detect Recurrent Bladder Tumors
Friday, 17 February 2006
BERKELEY, CA (UroToday.com) - The purpose of urinary bladder markers is ideally to minimize the need for cystoscopy in the detection of bladder cancer.
read more
|
European Urology - Watchful Waiting for Low-Grade Ta Bladder Tumours: The Idea would have been Unacceptable 30 Years Ago, but Nowadays We are Highly Interested in the Results of This Study Exploring It
Friday, 17 February 2006
In the 1970s, when intravesical chemotherapy and
BCG were developed, doctors advocated more
aggressive treatment against superficial bladder
tumours.
read more
|
Improving Sexual Function In Women Undergoing Radical Cystectomy
Monday, 13 February 2006
BERKELEY, CA (UroToday.com) - Radical cystectomy (RC) in women has historically included a complete anterior exenteration to include the lateral vaginal walls and urethra.
read more
|
Sex Hormones Play A Role In Bladder Cancer In Women
Friday, 10 February 2006
NEW YORK (Reuters Health) - Menopausal status as well as age at menopause may modify the risk of women developing bladder cancer, researchers suggest in the February 1st issue of the American Journal of Epidemiology.
read more
|
A Shared Environment And Husband With Cancer Does Not Increase Risk Of Breast Cancer For The Wife
Thursday, 09 February 2006
BERKELEY, CA (UroToday.com) - Spouses share epigenetic exposures such as environment, diet, and lifestyle to include stress. As such, it is plausible that a husband with a diagnosis of cancer may correlate with an increased incidence of cancer in the wife.
read more
|
Heavy Marijuana Use Linked To Higher Risk Of Bladder Cancer
Tuesday, 07 February 2006
NEW YORK (Reuters Health) - A new study suggests marijuana smoking increases the risk of transitional cell bladder carcinoma, according to the results of a study of middle-age men who were seen at two Veterans Administration facilities.
read more
|
Lilly Initiates Clinical Trials On Second Cancer Drug Discovered In Isis Collaboration
Tuesday, 07 February 2006
CARLSBAD, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that Eli Lilly and Company (NYSE: LLY) has initiated clinical trials of LY2275796 in cancer patients.
read more
|
Ask The ASCO Expert Events In March On PLWC
Friday, 03 February 2006
During the month of March, the American Society of Clinical Oncology's
(ASCO) patient information website, People Living With Cancer (www.plwc.org) will host two Ask the ASCO Expert events.
read more
|
Atorvastatin Acts Against Bladder Cancer In Vitro
Wednesday, 01 February 2006
NEW YORK (Reuters Health) - Atorvastatin, the widely prescribed HMG-CoA reductase inhibitor, shows significant action against human carcinoma cells, according to researchers.
read more
|
BJUI Mini Reviews - Lymphadenectomy for Invasive Bladder Cancer: I. Historical Perspective and Contemporary Rationale
Wednesday, 01 February 2006
This review evaluates the historical development and contemporary rationale for a lymphadenectomy in patients undergoing radical cystectomy.
Login to read more...
|
BJUI Mini Reviews - Lymphadenectomy for Invasive Bladder Cancer. II. Technical Aspects and Prognostic Factors
Wednesday, 01 February 2006
This review discusses the technical issues related to the
LND and its pathological analysis.
Login to read more...
|
BCG Plus Electromotive MMC May Be Superior To BCG Alone For Stage PT1 Bladder Cancer
Monday, 30 January 2006
BERKELEY, CA (UroToday.com) - Intravesicle BCG and Mitomycin C (MMC) are proven to decrease the recurrence rates of stage Ta, T1 and CIS bladder cancer.
read more
|
Role Of Voided Urine NMP22 Point-Of-Care Assay Clarified For Bladder Cancer Surveillance
Monday, 23 January 2006
BERKELEY, CA (UroToday.com) - Bladder cancer surveillance has traditionally consisted of a combination of cystoscopy, urine cytology, and upper urinary tract imaging.
read more
|
Matritech's NMP22 BladderChek Test Detects Bladder Cancers In Symptomatic Patients Missed By Traditional Laboratory Test
Thursday, 19 January 2006
Savannah, Georgia (January 19, 2006) -Giora Katz, M.D., a urologist with the Lake City Veterans' Hospital in Lake City, Florida reported today that in a recent bladder cancer clinical trial including veterans hospitals, Matritech's NMP22 BladderChek Test detected three times more cases of bladder cancer in symptomatic patients than the traditional laboratory test, cytology.
read more
|
Study In The Journal of American Medical Association (JAMA) Reports Significant Improvement In Bladder Cancer Detection - 99% Of Malignancies Found
Wednesday, 18 January 2006
JAMA Reports that the NMP22® BladderChek® Test is Better at Detecting Bladder Malignancies than Current Technologies
read more
|
Urine Test Helps Detect Recurrent Bladder Cancer
Wednesday, 18 January 2006
NEW YORK (Reuters Health) - A point-of-care proteomic test that looks for nuclear matrix protein NMP22 in urine is a useful adjunct to cystoscopy in detecting recurrent bladder cancer, new research suggests.
read more
|
FISH Effective For Detecting And Monitoring Transitional Cell Carcinoma
Tuesday, 17 January 2006
NEW YORK (Reuters Health) - Fluorescence in situ hybridization (FISH) is highly sensitive in detecting new and recurrent transitional cell carcinoma of the bladder, according to a report in the December 2005 BJU International.
read more
|
Shorter Dwell Time Eases BCG Side Effects In Bladder Cancer
Thursday, 12 January 2006
NEW YORK (Reuters Health) - In bladder cancer patients with severe side effects from instillation treatment with bacillus Calmette-Guerin (BCG), reducing the dwell time may offer an alternative to reducing the dose, Swedish researchers report.
read more
|
Diagnostic Ultrasound Corporation, Maker Of The BladderScan®, Partners With International Volunteers In Urology To Sponsor Traveling Resident Scholars
Wednesday, 04 January 2006
Bothell, Wash., January 4, 2006 - Diagnostic Ultrasound Corporation (DU) is pleased to announce an agreement with International Volunteers in Urology (IVU) to sponsor two traveling resident scholars during the 2006-2007 scholarship year.
read more
|
BJUI Mini Reviews - Structural Characterization of Myofibroblasts in the Bladder
Monday, 02 January 2006
In this review, we draw attention to several areas that have caused difficulties in clarifying the physiological processes to which they may contribute
Login to read more...
|
High Grade Superficial Bladder Cancer: A Second TUR Improves Response To Intravesical BCG
Friday, 23 December 2005
BERKELEY, CA (UroToday.com) - The literature suggests that patients with high grade T1 bladder cancer may be upstaged 40 - 70% of the time after repeat resection, especially if detrusor was not present in the initial specimen.
read more
|
Review Examines Complications Of Transurethral Bladder Tumor Resection In A Residency Setting
Tuesday, 20 December 2005
BERKELEY, CA (UroToday.com) - The initial diagnosis of a suspected bladder tumor is confirmed by the pathological examination of tissue obtained during transurethral resection.
read more
|
Lymphovascular Invasion Independently Predicts Decreased Survival In Patients With Upper Tract Transitional Cell Carcinoma
Thursday, 15 December 2005
BERKELEY, CA (UroToday.com) - The presence of lymphovascular invasion (LVI) has been correlated with an increased incidence of lymph node metastasis and decreased survival in patients with transitional cell carcinoma of the bladder.
read more
|
Bladder Cancer Support Groups And Community Outreach
Thursday, 15 December 2005
This update provides resources and ideas use within your organization. The bladder cancer education outreach programs at Western Urologic Associates in Colorado are explained by Martha Ruschival, RN.
read more
|
Bladder Perforation During Transurethral Resection Of Bladder Tumors More Common Than Believed Or Reported But Does Not Impose Significant Risks
Wednesday, 07 December 2005
BERKELEY, CA (UroToday.com) - Perforation is one of the frightening complications of transurethral resection of bladder tumors (TURBT) and is usually a consequence of an inadvertent full thickness bladder wall resection.
read more
|
Risk Factors For Complications Following Radical Cystectomy Identified In Large VA Database
Tuesday, 29 November 2005
BERKELEY, CA (UroToday.com) - Complication rates following radical cystectomy have been reported to be in the range of 28-32%.
read more
|
New Serosal Lined Antireflux Ureteroileal Implantation Technique On A GIA Stapler Detubularized Ileal Neobladder Reviewed
Friday, 18 November 2005
BERKELEY, CA (UroToday.com) - The importance of an antireflux ureteral reimplantation after orthotopic bladder replacement is a much debated question.
read more
|
Health Briefs for Everyone / Bladder Cancer: New Tool for Early Detection
Friday, 11 November 2005
Matritech, Inc., the maker of the NMP22® BladderChek® test, is dedicated to providing medical professionals with the resources to increase bladder cancer awareness.
read more
|
Bladder Cancer Awareness ? Early Detection Saves Lives
Friday, 11 November 2005
According to the National Cancer Institute, the prevalence of bladder cancer in the U.S. has surpassed that of lung cancer.
read more
|
Age And Comorbiditity Impact Surgical Therapy In Older Bladder Carcinoma Patients. A Population Based Study
Thursday, 10 November 2005
BERKELEY, CA (UroToday.com) - Recent population based studies suggest that the academic principles for treating muscle invasive bladder cancer may not be regularly applied in the general population.
read more
|
Multicenter Study Reports On ImmunoCyt Urine Test To Detect Bladder Cancer
Friday, 04 November 2005
BERKELEY, CA (UroToday.com) - The natural history of transitional cell carcinoma of the bladder includes tumor recurrence and progression in up to 70% and 25%, respectively.
read more
|
Older Patients Less Likely To Get Best Care For Invasive Bladder Cancer
Friday, 04 November 2005
NEW YORK (Reuters Health) - A new population-based study has found patients 75 or older with invasive bladder cancer are less likely to receive the recommended surgical treatment for the disease, even after comorbidity is taken into account.
read more
|
BJUI Mini Reviews - Intravesical Gemcitabine for Superficial Bladder Cancer: Rationale for a New Treatment Option
Tuesday, 01 November 2005
The present overview
will address the rationale and the initial
results of intravesical gemcitabine as a novel
chemotherapeutic agent for SBC.
Login to read more...
|
Urinary Telomerase An Accurate Test For Bladder Cancer
Thursday, 27 October 2005
NEW YORK (Reuters Health) - Urinary telomerase levels, determined by a telomeric repeat amplification protocol (TRAP)
assay, is a sensitive and specific marker of bladder tumors, even those of low grade, Italian investigators report in
the October 26th issue of the Journal of the American Medical Association.
read more
|
Approach To Urologic Malignancies In Solid Organ Transplant Patients
Friday, 21 October 2005
BERKELEY, CA (UroToday.com) - Patients with solid organ transplants are at risk for tumor development in their native as well as transplanted organs.
read more
|
Bladder Cancer 
